(Q35936259)

11 August 2017

1 reference

title

A review of the treatment for refractory obsessive-compulsive disorder: from medicine to deep brain stimulation (English)

1 reference

11 August 2017

main subject

deep brain stimulation

1 reference

obsessive-compulsive disorder

inferred from title

1 reference

David S Husted

1

1 reference

11 August 2017

Nathan A Shapira

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

9

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

833-847

1 reference

Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Relapses after discontinuation of drug associated with increased resistance to treatment in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Mirtazapine treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Defining the neuromolecular action of myo-inositol: application to obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Cingulotomy for refractory obsessive-compulsive disorder. A long-term follow-up of 33 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Anterior cingulotomy for refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Contributions of anterior cingulate cortex to behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Brain responses to changes in bladder volume and urge to void in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Inositol versus placebo augmentation of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: a double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Inositol treatment of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Bilateral orbitomedial leucotomy for obsessive-compulsive disorder: a single-case study using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Stereotactic limbic leucotomy: neurophysiological aspects and operative technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Stereotactic radiofrequency thermal cingulotomy for obsessive compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The cortico-striate projection in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The anatomical connections of the macaque monkey orbitofrontal cortex. A review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Cingulate cortex of the rhesus monkey: II. Cortical afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Cognitive therapy with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Behaviour therapy for obsessive-compulsive disorder: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Obsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Quetiapine augmentation in patients with treatment resistant obsessive-compulsive disorder: a single-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Which SSRI? A meta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Pharmacological treatment of childhood obsessive-compulsive disorder: from theory to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The use of antibody D8/17 to identify B cells in adults with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Orbital Frontal and Amygdala Volume Reductions in Obsessive-compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Are musical obsessions a temporal lobe phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The Yale-Brown Obsessive Compulsive Scale. II. Validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The concealment of obsessions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The epidemiology of obsessive-compulsive disorder in five US communities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Seizures in healthy people with repeated "safe" trains of transcranial magnetic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

The cognitive-affective neuroscience of obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Non-invasive magnetic stimulation of human motor cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Long-term electrical capsular stimulation in patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Transcranial magnetic stimulation: applications in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Novel physical treatments for the management of neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

A.E. Bennett Research Award. Anatomic basis for differential regulation of the rostrolateral peri-locus coeruleus region by limbic afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Review of long-term results of stereotactic psychosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Treatment of obsessive-compulsive disorder by psychosurgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Predictors of treatment outcome in the behavioural treatment of obsessive-compulsive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Is the 5-HT1DβReceptor Gene Implicated in the Pathogenesis of Obsessive-Compulsive Disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Association of QEEG findings with clinical characteristics of OCD: evidence of left frontotemporal dysfunction

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

A magnetic resonance imaging study of regional cortical volumes following stereotactic anterior cingulotomy.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns]

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Clomipramine, fluoxetine, and behavior therapy in the treatment of obsessive-compulsive disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Anxiety disorders following miscarriage

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Uncomplicated and comorbid obsessive-compulsive disorder in an epidemiologic sample

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS).

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Venlafaxine in treatment-resistant obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

https://api.crossref.org/works/10.1017%2FS109285290000225X

1 reference

7 January 2021

Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

Behavior therapy and tricyclic medication in the treatment of obsessive-compulsive disorder: a quantitative review

1 reference

https://api.crossref.org/works/10.1017%2FS109285290000225X

7 January 2021

10.1017/S109285290000225X

Identifiers

DOI

1 reference

11 August 2017

1 reference